Patents by Inventor Paul Masci

Paul Masci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11103560
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: August 31, 2021
    Assignee: Q-SERA PTY LTD.
    Inventors: Paul Masci, Kong-Nan Zhao, Martin Lavin, John De Jersey, Goce Dimeski
  • Publication number: 20210000925
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Application
    Filed: August 4, 2020
    Publication date: January 7, 2021
    Inventors: Paul MASCI, Kong-Nan ZHAO, Martin LAVIN, John DE JERSEY, Goce DIMESKI
  • Patent number: 10786553
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: September 29, 2020
    Assignee: Q-SERA PTY LTD.
    Inventors: Paul Masci, Kong-Nan Zhao, Martin Lavin, John De Jersey, Goce Dimeski
  • Publication number: 20190390248
    Abstract: This invention relates to the use of clotting compositions containing prothrombin activators to produce high quality blood serum samples for pathology and other biological assays, and to containers containing such clotting compositions, and related methods of use.
    Type: Application
    Filed: July 5, 2019
    Publication date: December 26, 2019
    Inventors: Paul Masci, John De Jersey, Martin Lavin, Julie Phillips, Goce Dimeski
  • Patent number: 10385381
    Abstract: This invention relates to the use of clotting compositions containing prothrombin activators to produce high quality blood serum samples for pathology and other biological assays, and to containers containing such clotting compositions, and related methods of use.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: August 20, 2019
    Inventors: Paul Masci, John De Jersey, Martin Lavin, Julie Phillips, Goce Dimeski
  • Publication number: 20170304407
    Abstract: The present invention relates to improved clotting compositions for producing high quality blood serum samples for analyte testing, such as for pathology testing and other biological assays. In particular, the present invention relates to the use of prothrombin activators in combination with stabilizing agents such as colloids for producing high quality blood serum samples. The present invention also relates to associated methods for preparing clotting compositions, tubes, kits and methods of diagnosis, prognosis and monitoring for responsiveness to therapy.
    Type: Application
    Filed: October 23, 2015
    Publication date: October 26, 2017
    Inventors: Paul Masci, Kong-Nan Zhao, Martin Lavin, John De Jersey, Goce Dimeski
  • Publication number: 20130273584
    Abstract: This invention relates to the use of clotting compositions containing prothrombin activators to produce high quality blood serum samples for pathology and other biological assays, and to containers containing such clotting compositions, and related methods of use.
    Type: Application
    Filed: September 20, 2011
    Publication date: October 17, 2013
    Applicant: THE UNIVERSITY OF QUEENSLAND
    Inventors: Paul Masci, John De Jersey, Martin Lavin, Julie Phillips
  • Patent number: 7070969
    Abstract: The invention provides novel single stage competitive inhibitors of plasmin from the Australian brown snake Pseudonaja textilis textilis. The invention also features polynucleotides and polynucleotide homologues encoding these inhibitors. Pharmaceutical compositions containing the plasmin inhibitors of the invention are also disclosed as well as methods useful for treatment of blood loss.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: July 4, 2006
    Assignees: The University of Queensland, National Institute of Biological Standards and Control
    Inventors: Pantaleone Paul Masci, Martin Francis Lavin, Patrick Joseph Gaffney